Senex Therapeutics
Ageing and stress have been identified as potential contributors to inflammation. While stress-related inflammation often subsides on its own, there are instances where it evolves into a chronic condition. Prolonged or chronic inflammation can give rise to severe health issues, causing irreversible damage to the body. SENEX aims to disrupt the cycle of chronic inflammation through the utilization of AAV-mediated gene therapy. Initially, the company is concentrating its efforts on addressing Pulmonary Arterial Hypertension and Osteoarthritis.
7-day free trial · no credit card
Verified contacts
2
available on Kipplo
LinkedIn employees
3
1 to 10 range
Open roles
—
no listings
Distinct roles
0
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 2 verified contacts at Senex Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
2 contacts with verified email or phone · masked until revealed.
No verified contacts on record for this company yet.
Sign up to unlock all 2 contacts at Senex Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 2 verified contacts at Senex Therapeutics
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.